New DNA test predicts chemotherapy resistance in cancer patients
View as a Web Page
News Medical
 
  Ovarian Cancer Ovarian Cancer logo  
  The latest ovarian cancer news from News Medical  
 Mayo Clinic researchers discover how ovarian cancer may beginMayo Clinic researchers discover how ovarian cancer may begin
 
Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when someone is diagnosed with ovarian cancer, it has already progressed to stage 3 or stage 4, which means it has spread to other parts of the body.
 
 
 New DNA test predicts chemotherapy resistance in cancer patientsNew DNA test predicts chemotherapy resistance in cancer patients
 
Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer Research Centre (CNIO) and Cambridge-based startup Tailor Bio, have created a test which can successfully predict whether cancer will resist common forms of chemotherapy treatment.
 
   Predicting deep vein thrombosis in patients with epithelial ovarian cancer using a nomogramPredicting deep vein thrombosis in patients with epithelial ovarian cancer using a nomogram
 
Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide personalized treatment to formulate preventive measures for various diseases.
 
 Study reveals the genetic underpinnings of a rare and aggressive ovarian cancer
 
A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
 
 
 OCCAM Immune and Cancer Research Institute join forces to advance immunotherapy
 
OCCAM Immune and Cancer Research Institute join forces to advance immunotherapyIn a new collaboration that could transform how cancer is treated, OCCAM Immune-a Mount Sinai initiative focused on understanding the immune system's role in disease-is partnering with the Cancer Research Institute (CRI) to unlock the secrets of how the immune system responds to advanced therapies.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025